|
|
|
|
|
by hcknwscommenter
2263 days ago
|
|
Typically, you first test the blood to see if there are any antibodies in that blood of interest. E.g., collect blood sample, harvest serum from blood by coagulation and centrifugation, apply serum to surface coated with COVID protein(s), wash away unbound material, detect whether antibodies to serum have bound to surface coated with COVID proteins. If yes, then this is a blood sample of interest. You could also test for neutralizing antibodies in parallel/before/after/instead in a viral replication assay. Once you have identified the blood as containing what you want, you then harvest more and collect mature B cells. Mature B cells each produce one antibody. You isolate the B cells by limiting dilution and/or immortalize them by fusion with a special type of cell to make a hybridoma to isolate clonal populations of single cells that are maintainable. Then you test each clonal population for whether it produces the antibody of interest, isolate the nucleic acid that encodes that antibody and put it into a cell type suitable for manufacturing. There are other ways to do it, but the above is fairly standard. It is laborious and easy to mess up and takes time (1 to 2 months) to do correctly. Any step can go wrong and require starting over. |
|
Do people actually still do it this way? I would have thought that you would use more targeted approaches where you use an antigen to fish for cells of interest before culturing. There are a few such techniques described here:
https://www.frontiersin.org/articles/10.3389/fimmu.2019.0169...
Naively, i would have thought you could do something with affinity columns or magnetic beads, too - coat beads with antigen, then use those to extract B cells expressing a matching surface immunoglobulin.